These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 11214219)
41. Kinetic analysis of the interactions between troponin C (TnC) and troponin I (TnI) binding peptides: evidence for separate binding sites for the 'structural' N-terminus and the 'regulatory' C-terminus of TnI on TnC. Tripet B; De Crescenzo G; Grothe S; O'Connor-McCourt M; Hodges RS J Mol Recognit; 2003; 16(1):37-53. PubMed ID: 12557238 [TBL] [Abstract][Full Text] [Related]
42. A mutation in the N-terminus of troponin I that is associated with hypertrophic cardiomyopathy affects the Ca(2+)-sensitivity, phosphorylation kinetics and proteolytic susceptibility of troponin. Gomes AV; Harada K; Potter JD J Mol Cell Cardiol; 2005 Nov; 39(5):754-65. PubMed ID: 16005017 [TBL] [Abstract][Full Text] [Related]
43. Application of recombinant antibody fragments for troponin I measurements. Altshuler EP; Vylegzhanina AV; Katrukha IA; Bereznikova AV; Serebryanaya DV Biochemistry (Mosc); 2012 Dec; 77(12):1362-7. PubMed ID: 23244731 [TBL] [Abstract][Full Text] [Related]
44. Tissue expression of four troponin I genes and their molecular interactions with two troponin C isoforms in Caenorhabditis elegans. Ruksana R; Kuroda K; Terami H; Bando T; Kitaoka S; Takaya T; Sakube Y; Kagawa H Genes Cells; 2005 Mar; 10(3):261-76. PubMed ID: 15743415 [TBL] [Abstract][Full Text] [Related]
45. Impact of antibody specificity and calibration material on the measure of agreement between methods for cardiac troponin I. Newman DJ; Olabiran Y; Bedzyk WD; Chance S; Gorman EG; Price CP Clin Chem; 1999 Jun; 45(6 Pt 1):822-8. PubMed ID: 10351991 [TBL] [Abstract][Full Text] [Related]
46. Use of a dual monoclonal solid phase and a polyclonal detector to create an immunoassay for the detection of human cardiac troponin I. Oh SK; Foster K; Datta P; Orswell M; Tasaico K; Mai X; Connolly P; Reamer R; Walsh R; Yang G; Barlow E; Bluestein B; Parsons G Clin Biochem; 2000 Jun; 33(4):255-62. PubMed ID: 10936582 [TBL] [Abstract][Full Text] [Related]
47. Overexpression of human cardiac troponin-I and troponin-C in Escherichia coli and their purification and characterisation. Two point mutations allow high-level expression of troponin-I. al-Hillawi E; Minchin SD; Trayer IP Eur J Biochem; 1994 Nov; 225(3):1195-201. PubMed ID: 7957210 [TBL] [Abstract][Full Text] [Related]
48. A comparison of capture antibody fragments in cardiac troponin I immunoassay. Hyytiä H; Järvenpää ML; Ristiniemi N; Lövgren T; Pettersson K Clin Biochem; 2013 Aug; 46(12):963-968. PubMed ID: 23370114 [TBL] [Abstract][Full Text] [Related]
49. Formulation of immunoassay calibrators in pasteurized albumin can significantly enhance their durability. Warren DJ; Nordlund MS; Paus E J Immunol Methods; 2010 Feb; 353(1-2):145-7. PubMed ID: 20006616 [TBL] [Abstract][Full Text] [Related]
50. Expression and assembly of active human cardiac troponin in Escherichia coli. Lassalle MW Protein Expr Purif; 2013 Feb; 87(2):61-6. PubMed ID: 23116770 [TBL] [Abstract][Full Text] [Related]
51. Overcoming difficulties on synthesis of cardiac troponin-I. Selimoglu SM; Kasap M; Akpinar G; Karadenizli A Prep Biochem Biotechnol; 2017 Jan; 47(1):94-99. PubMed ID: 27070210 [TBL] [Abstract][Full Text] [Related]
52. Negative interference in cardiac troponin I immunoassays by circulating troponin autoantibodies. Eriksson S; Halenius H; Pulkki K; Hellman J; Pettersson K Clin Chem; 2005 May; 51(5):839-47. PubMed ID: 15718489 [TBL] [Abstract][Full Text] [Related]
53. Development of a candidate secondary reference procedure (immunoassay based measurement procedure of higher metrological order) for cardiac troponin I: I. Antibody characterization and preliminary validation. Noble JE; Bunk DM; Christenson RH; Cole KD; He HJ; Katrukha AG; Panteghini M; Porter RA; Schimmel H; Tate JR; Wang L; Clin Chem Lab Med; 2010 Nov; 48(11):1603-10. PubMed ID: 21062228 [TBL] [Abstract][Full Text] [Related]
54. Antigenic definition of cardiac troponin I. Larue C; Ferrieres G; Laprade M; Calzolari C; Granier C Clin Chem Lab Med; 1998 Jun; 36(6):361-5. PubMed ID: 9711422 [TBL] [Abstract][Full Text] [Related]
55. Removal of endotoxin from recombinant protein preparations. Liu S; Tobias R; McClure S; Styba G; Shi Q; Jackowski G Clin Biochem; 1997 Aug; 30(6):455-63. PubMed ID: 9316739 [TBL] [Abstract][Full Text] [Related]
56. Appropriate sera for calibration and control of specific protein assays. Blaabjerg O; Blom M; Gry H; Petersen PH; Uldall A Scand J Clin Lab Invest Suppl; 1993; 212():13-5. PubMed ID: 8465145 [TBL] [Abstract][Full Text] [Related]
58. Extra leader sequence affects immunoactivity of cardiac troponin I. Liu S; Zhang MY; Song Q; Zhang X; Kadijevic L; Shi Q Clin Chem; 1999 Aug; 45(8 Pt 1):1300-2. PubMed ID: 10430804 [No Abstract] [Full Text] [Related]
59. Precolumn affinity capillary electrophoresis for the identification of clinically relevant proteins in human serum: application to human cardiac troponin I. Dalluge JJ; Sander LC Anal Chem; 1998 Dec; 70(24):5339-43. PubMed ID: 9868922 [TBL] [Abstract][Full Text] [Related]
60. Current techniques for the study of troponin I phosphorylation in human heart. Gallon CE J Muscle Res Cell Motil; 2008; 29(6-8):169-72. PubMed ID: 19172403 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]